Eribulin Advanz Pharma 0.44 mg / ml solution for injection

Licence status
Authorised: 22/09/2023
Active substances
Eribulin mesylate
Dosage Form
Solution for injection
Licence number
PA23450/001/001
Licence holder
Advanz Pharma Limited

Product documents

Licence information

ATC code
L01XX41 eribulin
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2)
Marketing availability
Not marketed
Advertising conditions
Advertising to healthcare professionals only
Licence issued
22/09/2023